Biomarkers for non-small cell lung cancer immunotherapy

Biomarkers for non-small cell lung cancer immunotherapy

The discovery of immune checkpoint inhibition has revolutionized the treatment of many solid malignancies, including non-small cell lung cancer (NSCLC). Immune checkpoint inhibitors (ICI) can restore the antitumor immune response by blocking the inhibition of T-cell activation. Anti-programmed death...

Full description

Saved in:
Bibliographic Details
Main Authors: D. A. Kharagezov, Yu. N. Lazutin, E. Yu. Zlatnik, A. B. Sagakyants, E. A. Mirzoyan, A. G. Milakin, O. N. Stateshny, A. V. Chubaryan, I. A. Leyman
Format: Article
Language:Russian
Published: ANO "Perspective of oncology" 2021-09-01
Series:Южно-Российский онкологический журнал
Subjects:
non-small cell lung cancer
immunotherapy
biomarkers
checkpoint inhibitor
anti-programmed deathligand 1
tumor mutation burden
Online Access:https://www.cancersp.com/jour/article/view/112
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.cancersp.com/jour/article/view/112

Similar Items